During the past decade, Kinderklinik d. TU / Schwabing conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kinderklinik d. TU / Schwabing" #1 sponsor was "Universitätsklinikum Hamburg-Eppendorf" with 2 trials, followed by "Christine Mauz-Körholz" with 1 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 1 trials sponsored, "Martin Schrappe" with 1 trials sponsored and "University Hospital Schleswig-Holstein" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinderklinik d. TU / Schwabing" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 1 trials as a collaborator and "Martin-Luther-Universität Halle-Wittenberg" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kinderklinik d. TU / Schwabing" are "Acute Lymphoblastic Leukemia, Pediatric" (1 trials), "Brain Tumors" (1 trials), "Childhood Brain Tumor" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Kinderklinik d. TU / Schwabing" in a lesser frequency.

Most popular intervention types in "Kinderklinik d. TU / Schwabing" are "Drug" (5 trials), "Radiation" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "etoposide" (3 trials), "vincristine sulfate" (3 trials) and "ifosfamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kinderklinik d. TU / Schwabing" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kinderklinik d. TU / Schwabing". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kinderklinik d. TU / Schwabing, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kinderklinik d. TU / Schwabing, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".